Regulus Therapeutics was created in 2007-09.
The population of Regulus Therapeutics is 54.
The symbol for Regulus Therapeutics Inc. in NASDAQ is: RGLS.
Regulus Therapeutics Inc. (RGLS) had its IPO in 2012.
As of July 2014, the market cap for Regulus Therapeutics Inc. (RGLS) is $292,658,548.50.
regulus therapeutics
Halozyme Therapeutics was created in 1998.
Silence Therapeutics was created in 1994.
Acorda Therapeutics was created in 1995.
IL Therapeutics was created in 2005.
Edge Therapeutics was created in 2009.
TauRx Therapeutics was created in 2002.
Prime Therapeutics was created in 1998.